Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Wilms Tumor 5 Rhabdoid Tumor 5 Osteosarcoma 5 Neuroectodermal Tumors, Primitive, Peripheral 5 Neuroblastoma 5 Medulloblastoma 5 Lymphoma, Non-Hodgkin 5 Histiocytosis, Langerhans-Cell 5 Hepatoblastoma 5 Glioma 5 Ependymoma 5 Sarcoma 4 Rhabdomyosarcoma 4 Central Nervous System Neoplasms 4 Sarcoma, Ewing 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroendocrine Tumors 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Burkitt Lymphoma 2 Xanthogranuloma, Juvenile 1 Thyroid Cancer, Papillary 1 Non functioning pancreatic endocrine tumor 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Lymphoma 1 Histiocytic Sarcoma 1 Familial ependymoma 1 Breast Neoplasms 1 Anus Neoplasms 1

Interventions

pembrolizumab 18 Specimen Handling 16 Magnetic Resonance Spectroscopy 11 Biopsy 11 Paclitaxel 8 Carboplatin 8 trastuzumab deruxtecan 6 Pemetrexed 6 Nivolumab 6 Irinotecan 6 Fulvestrant 6 Bevacizumab 6 Radiosurgery 5 Leucovorin 5 Gemcitabine 5 Fluorouracil 5 Cetuximab 5 palbociclib 4 Oxaliplatin 4 Letrozole 4 Cisplatin 4 olaparib 3 durvalumab 3 Taxes 3 Ipilimumab 3 Docetaxel 3 Capecitabine 3 130-nm albumin-bound paclitaxel 3 sacituzumab govitecan 2 ribociclib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Phantoms, Imaging × 30 days × Clear all

NCT03842228 2026-05-29

COD

National Cancer Institute (NCI)

Phase 1 Active not recruiting

39 enrolled 15 charts

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡